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Next steps after grant rejection
– Amy Ninetto
Getting bad news about a grant application is discouraging, but for most funding opportunities,
applicants whose original application is rejected have the option to prepare and submit a
resubmission. In a recent All About Grants podcast and a session of the US National Institutes of
Health (NIH) November 2021 Virtual Seminar on Program Funding and Grants Administration,
NIH program officers offered helpful advice for preparing a resubmission. The program officers’
advice can be summarized into 10 steps to take to help improve your chances of getting your
resubmission funded. Although the advice here is from NIH, much of it also applies to dealing
with grant rejections from other funders.
1. Take a few days after receiving your summary statement to calm your emotions. Don’t take
criticism personally. As Dr. Kristine Willis, Program Officer at the National Cancer Institute,
remarked, “It’s not that [the reviewers] don’t like you… It’s not that they don’t like your science.
They just didn’t like this particular arrangement of words on the page.”

2. Make a plan. Read the summary statement carefully and start making a plan for
resubmission. Think about what you could do fairly quickly to address reviewers’ concerns—for
example, rewriting unclear sections, reviewing additional literature, conducting additional
statistical analyses, or performing some straightforward lab work—and what might take longer.
3. Reach out to your program officer. The panelists stressed that investigators planning a
resubmission should always contact their program officer. According to Dr. Jennifer Troyer,
Program Officer at the National Human Genome Research Institute, program officers see
thousands of applications and understand what drives reviewers’ scores. In addition, they attend
study section meetings, so they may be able to give you a more nuanced account of the
perceived strengths and weaknesses of your original application than the summary statement
does.
Don’t cold call your program officer; instead, email them to set up a time to meet virtually or by
telephone. If you can, email them specific questions or concerns or an outline of your plans for
revisions so that they can prepare for your conversation.
4. Keep up with your field. Revised grants usually must be submitted within 37 months of the
original application. Keep in mind that, as noted by Dr. Shawn Gaillard, Program Officer at the
National Institute of General Medical Sciences, “science moves at warp speed.” Especially if a lot
of time has passed since your original submission, your resubmission should demonstrate that
you have read recent literature and kept up with new technology in your field.
5. Respond thoroughly and professionally. Dr. Sige Zou from the NIH Office of Research
Infrastructure Programs stressed that “your resubmission should be highly responsive.”
Resubmitted applications are reviewed by the same study section as the original application;
they may not have the same primary reviewers, but those reviewers may still be members of the
study section. Reviewers of resubmitted applications have access to the summary statement for
the original submission and do consider whether the previous reviewers’ concerns have been
adequately addressed.
In the introduction page to your resubmission, summarize the reviewers’ criticisms and then
address them all politely and constructively. (See “Tips for writing Introduction sections for NIH
resubmission grant applications,” The Write Stuff, Summer 2017.) Dr. Zou advised that if you
can’t address a concern or disagree with it, the introduction should provide the reasons why—
don’t simply ignore such criticisms. (See “How to disagree with an NIH research grant proposal
review,” The Write Stuff, Winter 2019.) The introduction should also clearly indicate what has
changed in the resubmitted proposal. The NIH no longer requires you to mark changes in the
Research Strategy document.
6. Seek advice from mentors and colleagues who have been through the resubmission process
and those who have served on study sections. People outside your field can often help you
review your application for clarity. The INTEREST program at MD Anderson holds mock study
sections in which MD Anderson faculty review and provide feedback on grant proposals. Editors

in the Research Medical Library can also help improve the readability and organization of your
proposal.
7. Work with your strengths. “I’m always telling people…to not just focus on what was said
that was negative, but also remember to focus on what was said that was positive and build off
of the positives,” said Dr. Troyer. Dr. Amanda Melillo, Program Officer at the National Institute of
Dental and Craniofacial Research, recommended revising the weaknesses identified by reviewers
while being careful not to change elements the reviewers liked. It’s also important not to remove
important details from the original to save space. Highlight your ongoing work by including new
findings or new preliminary data.
8. Reread the Funding Opportunity Announcement (FOA). Revising a grant proposal can
take some time. Many NIH FOAs expire after 3 years, so make sure that the FOA still applies at
the time of your resubmission and hasn’t changed. (See “NIH tip: Check your funding
opportunity announcement 30 days before submitting your grant application,” The Write Stuff,
Spring 2019.) Most FOAs allow resubmissions, but a few do not, so also check to make sure the
FOA to which you are applying does so.
9. Avoid common errors. The panelists mentioned several common errors that reduce your
chances of receiving a fundable score, among them not contacting your program officer and
failing to respond thoroughly to the reviewers’ comments. Dr. Willis also advised investigators
preparing a resubmission not to miss “the forest for the trees”—that is, not to focus on technical
details to the extent that the bigger picture of the reviewers’ critiques of the project is not
addressed. Finally, the panelists discussed the importance of clear communication, including
visual communication. The text should be clearly written, be well organized, and use—but not
overuse—bold text to highlight important points and review criteria. Paragraphs should be fairly
short and tightly focused. Figures and legends should be clear and readable, and the page
layout should make good use of white space.
10. Don’t give up. All of the panelists emphasized that, in most cases, it’s a good idea to revise
and resubmit an unfunded proposal—even if it wasn’t discussed. “All of us have seen an
application go from not discussed on the A0 [original submission] to scored in the fundable
range on the A1 [resubmission],” noted Dr. Willis. NIH data show that resubmitted applications
have higher success rates than initial submissions do. Unless the reviewers had major problems
with several of the review criteria, in which case you may need to reconceptualize the entire
study, try again. “The only way to not get funded is not to apply,” remarked Dr. Gaillard.
Sources
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Resources on new NIH policy for data management and sharing
– Bryan Tutt
Since 2013, the US National Institutes of Health (NIH) and other federal agencies have required
data management plans for all federally funded research (1). These plans must include
provisions for the long-term storage and sharing of data. Over the years, it became clear that
applicants for NIH grants needed more guidance on creating data management plans.
To provide specific instructions and to improve the reproducibility of NIH-funded research (2),
NIH in 2020 announced a revised data sharing and management policy, which since has been
revised on the basis of public feedback (3). The final policy (4) will go into effect for all grant
proposals submitted to NIH with due dates of January 25, 2023, and later. The policy also goes
into effect on this date for contract proposals and other funding agreements.
To help researchers familiarize themselves with these updates, NIH recently rolled out a website
(5) that describes the new data sharing policy in detail and clarifies definitions of key terms such
as scientific data, data management, data sharing, and metadata. This website provides
information about how the new policy applies to various types of research (e.g., genomics
studies, clinical trials) and an extensive list of NIH-supported scientific and genomic data
repositories.
The website also provides details on how to write a data management and sharing plan for NIH
grant proposals. In general, the data management and sharing plan can be up to 2 pages long
and is part of the Budget Justification section of the grant proposal. The plan should include the
following elements:
• Data type, which may include the modality (e.g., imaging, survey), amount (e.g., number
of participants or animals), level of aggregation (e.g., individual, aggregated,
summarized), and level of data processing; which data will be preserved and shared (and
the rationale for this decision); and a list of metadata and associated documentation
(e.g., study protocols, data collection instruments)
• Related tools, software, and/or code, particularly those needed to access the shared
scientific data or to support replication
• Standards that will be applied (e.g., data formats, data dictionaries, data identifiers,
definitions)
• Data preservation, access, and associated timelines, including the repository(ies)
where data will be stored, how the data will be found (e.g., unique identifier, standard
indexing tools), and when and for how long the data will be shared
• Access, distribution, or reuse considerations, such as informed consent, applicable
federal/state/Tribal legal restrictions (e.g., privacy and confidentiality laws), and whether
access to data from humans will be controlled
• Oversight of data management and sharing (e.g., how compliance will be managed
and monitored)

Additional information related to data management, sharing, and storage is available through
the Research Medical Library’s Data Management site.
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What should you include as supplemental material?
– Madison Semro
Authors of biomedical articles often must divide content between the main text and
supplemental material. Some may struggle with this decision, especially when it comes to tables
and figures.
Supplemental material is content directly relevant to the conclusions of an article that cannot be
included in the main content because of size and/or medium restrictions (1). In journals that
publish online and in print, the main text is published online and in a print version, while
supplemental material is usually published only online. Examples of supplemental material
include audio files, video clips, detailed descriptions of methods, and large data tables.
According to the National Information Standards Organization (NISO), there are two categories
of supplemental material: integral supplemental material, which is essential to understanding
the conclusions of an article, and additional supplemental material, which is relevant expansions
to an article that are not essential to understanding it (1). However, journals differ in how they
apply these definitions, so you should consult your target journal’s guidelines for supplemental
material. For example:
•

Cancer limits how many tables and figures authors can submit for publication with the
main text, but the journal allows authors to submit additional tables and figures as
“online-only supporting information,” which is “not essential to the article but provides
greater depth and background.”

•

•

JAMA Network journals accept supplementary material such as methods descriptions
and additional figures that are “important to the understanding and interpretation of the
report.” However, specific allowances depend on the manuscript type. For example, for
research letters, supplemental material for the methods but not the results may be
submitted.
Cell permits publication of materials that provide secondary support to the paper’s main
conclusions and cannot be otherwise included owing to file type or space restrictions.
The materials should “create conceptual associations with the items in the main paper in
order to give a complete picture.” Published examples include control data, methods
validations, media files, and code snippets.

Authors should also note that supplemental material typically receives less attention than
material in the main text because of time and size restraints (2). Supplemental material is not
always reviewed during the peer-review process, edited by the journal’s editorial staff, or viewed
by readers. According to a survey by the BMJ, only 27% of readers routinely read the entire
supplemental material (3). Thus, NISO warns that “content that is a critical part of the evidence
for the article’s conclusions can be lost to future readers if it is indiscriminately grouped with
other less crucial materials surrounding the article” (1).
Furthermore, different kinds of content are perceived differently when encountered in the
supplemental material. In the BMJ survey, 60% reported finding supplemental figures and tables
to be the most valuable type of supplemental material (3). In contrast, readers found raw data to
be the least useful. Respondents, who also included authors and peer-reviewers, also indicated
that some supplemental material, such as descriptions of a study’s methods, became much
more valuable if a reader was considering replicating the protocol.
In general, material that you find most vital to understanding your findings should be placed in
the main text because that is where all readers will encounter the material. However, no
universal approach exists for determining what material should be considered supplemental. It is
up to your best judgment and, in many cases, the final call of the journal editor.
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Tips for collaborating with manuscript authors online
– Don Norwood
Working with other authors on a manuscript is a rewarding experience when your article is
published. Getting to that point can be an arduous effort, though, particularly if you do not have
a plan for file management and collaboration with your colleagues.
Performing any study in the lab or clinic requires a substantial amount of preparation. Once the
study is complete, writing the report of your findings requires a lot of preparation as well. This
consists of several practical steps described below that will help you and your fellow authors
efficiently write and modify the manuscript. Also included are some options for managing
projects that are more extensive than manuscripts.
The master copy
The lead author should keep the master copy of the manuscript. The lead author should also be
the only one to make the final edits and changes to this copy before submission to the journal.
Maintaining a master copy will allow the lead author to track and consider all proposed changes
systematically during all stages of the writing process.
Workflow
Determine the order in which all authors read and comment on each draft of the manuscript.
This will make the writing process efficient and organized and help the authors fit writing and
editing into their other responsibilities.
Making changes
The authors should agree on how to submit comments, changes, and edits to the lead author.
This frequently consists of using the Comments and Track Changes features in Microsoft Word.
Under your Track Changes options, be sure to set the color for all markup items to “By author”.
This will ensure that the lead author knows who made the changes to the draft.
In addition, the lead author can have each co-author send a list of suggested changes to each
draft. The lead author can then make all the changes to the master copy, which is a lot of work
but will keep the lead author from missing any changes.
Draft naming
Use a document naming system for all of the drafts of your manuscript. Any system that works
for you should be okay, but one that includes the draft or version number as well as the author’s
name or initials is optimal. For example, “studyreport_v1_DN” consists of the name of the
manuscript followed by the version number and author’s initials. Although it will lengthen the
document name even more, authors can also add the date they submit the draft to the lead
author.

File sharing
Authors frequently use e-mail to distribute drafts of their papers to each other. Given the
volume of your e-mail inbox, however, adding to it might be the last thing you want. A good
alternative is to use an online file sharing system. The obvious choice at MD Anderson is
OneDrive. In OneDrive, you can create a folder (with subfolders) that will serve as a repository
for all of the drafts of your article. Another online file sharing system used at our institution is
SharePoint, although it is better suited for larger writing projects such as SPORE grants and
books.
Author meetings
Although they’re not always feasible, author meetings can keep writing projects on track and
make sure all of the authors maintain their focus. If you do have such meetings, designate
someone to take notes on or minutes of the meetings and store them in your online file sharing
system.
Project management
If organization and communication among your colleagues are high priorities, you can use a
project management software application when writing your manuscript. These applications
include Basecamp, Asana, and Trello. As with SharePoint, project management software
probably works better with writing projects larger than manuscripts.
High-quality research findings can be wasted if they’re not reported well. Having a plan for file
management and collaboration among authors will go a long way toward making sure that you
describe your study effectively.
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Unusual terms used in scientific writing and publishing: Overlay journal
– Sarah Bronson
Overlay journals are an open-access publishing model in which a journal selects articles that
have been archived on public open-access repositories and links to these articles or mirrors
them on its website, helping expand the articles’ reach (1). While overlay journals do not
themselves produce articles, most perform peer review before acceptance. This model has arisen
in part as a response to inequitable costs and access in scholarly publishing (2). Because of the
low overhead made possible by relying on existing repositories, several overlay journals have no
article-processing charges (1, 2).

Only a small number of overlay journals are active, and the majority of articles in these journals
are in computer and information sciences and physical sciences (1). Two examples of overlay
journals focused on medical sciences are eLife and JMIRx Med. eLife considers only research
articles that have been uploaded to a preprint server, and it uses peer review. It has been an
open-access journal since 2013 and transferred to the overlay model in 2022. The publication
fee for eLife is $3,000 but may be waived on a case-by-case basis.
JMIRx Med has no article-processing fees; costs are covered through a network of preprint
servers, peer-review services, and journals, a model known as Plan P. JMIRx Med uses what its
editor-in-chief calls an editorial prospecting platform, through which reviewers and editors find
papers on preprint servers and extend offers of publication to the authors. Authors also may
submit their preprints in a more traditional manner or be solicited to write reviews or
commentaries. JMIRx Med is part of a series of overlay journals launched in 2019, JMIRx, which
includes JMIRx Bio and JMIRx Psy; the three correspond to the preprint servers medRxiv, bioRxiv,
and PsyArXiv, respectively.
Although their presence in biomedical publishing is currently limited, overlay journals are an
innovation to watch.
References
1. Rousi AM, Laakso M. Overlay journals: a study of the current landscape. arXiv. 2022.
https://doi.org/10.48550/arXiv.2204.03383
2. How journals are using overlay publishing models to facilitate equitable OA. Scholastica.
Published October 25, 2019. https://blog.scholasticahq.com/post/journals-using-overlaypublishing-models-equitable-oa/

Editing services
The scientific editors in the Research Medical Library help MD Anderson faculty and trainees get
published and get funded. We provide a wide range of editorial, educational, and publishing
services, free of charge, to the MD Anderson community, including
• editing grant proposals and research articles;
• providing one-on-one consultations with authors at any stage of the writing process;
• teaching workshops and giving lectures on writing research articles and grant
proposals;
• teaching scientific English for non-native speakers; and
• providing writing advice and support, including online writing advice.
For more information about our editing services and how to use them, please visit Our Editing
Services, or contact us at RML-Editing@mdanderson.org.

Upcoming events for authors
Please see the Research Medical Library website for more information about educational courses, a
schedule of upcoming events, and recordings of past classes.

Asynchronous courses for writing manuscripts and K99/R00 proposals. Two scientific
writing workshops developed by our expert scientific editors are available as self-paced courses
in Study@MDAnderson for MD Anderson faculty, staff, and students. Upon completion, learners
will receive a certificate of completion.
Writing and Publishing Scientific Articles (WAPSA) guides participants through each step
of writing a biomedical research manuscript. Enroll in the self-paced course with your MD
Anderson address.
The K99/R00 grant proposal workshop provides practical advice on writing the Candidate
Section, Specific Aims, and Research Strategy of an NIH K99/R00 application. Enroll in the
self-paced course with your MD Anderson address.

New EndNote Office Hours with the Research Medical Library. Get answers to your EndNote
questions and learn how to address common problems in a live, virtual setting. Register for
upcoming sessions at 9 a.m. on September 5 and October 3, 2022.

INTEREST Program. The INTEREST program is a series of mock study sections that leverage the
expertise of experienced MD Anderson faculty in writing fundable research proposals. It involves
a rigorous review of extramural grant proposals to improve, critique, and offer experience in the
grant review process, from the applicant’s and the reviewer’s points of view. For more
information, contact INTEREST@mdanderson.org.
Important upcoming dates:
August 24, 2022 – Deadline to submit your (1) INTEREST Intent Form and (2) PDF copy of
the Abstract of the grant to INTEREST@mdanderson.org
August 31, 2022 – Full application submission deadline. Please submit a single PDF that
includes the proposal: abstract, aims, significance, innovation, research strategies,
references, and biosketch of PI and other key personnel (the standard NIH format except
the budget pages).
September 14, 2022 – INTEREST Review Meeting. The INTEREST study section will meet on
May 14, 2022, to review grants.

Introduction to Systematic Reviews. Thinking about writing a systematic review? This
introductory 30-minute class gives a quick overview and briefly describes the steps in the
process.
August 4, 2022 – Join the class here: https://mdacc.zoom.us/meeting/register/tZIpcurqjotE9Jxd6JlEcJ1xWLzbRJf5qpU

Resource Spotlight: iThenticate. Learn how to use the iThenticate software to check the
originality of your work, as well as interpret reports for a less challenging publishing process.
September 14, 2022 – Join the class here:
https://mdacc.zoom.us/meeting/register/tZ0lduGurjwiGNCQACl8NMSeVwJBjWiHmnRl
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material included in this newsletter may be freely distributed, as long as proper credit is
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